CN115975949B - 一种基于microRNA制备诱导性多能干细胞的方法 - Google Patents
一种基于microRNA制备诱导性多能干细胞的方法 Download PDFInfo
- Publication number
- CN115975949B CN115975949B CN202310265343.XA CN202310265343A CN115975949B CN 115975949 B CN115975949 B CN 115975949B CN 202310265343 A CN202310265343 A CN 202310265343A CN 115975949 B CN115975949 B CN 115975949B
- Authority
- CN
- China
- Prior art keywords
- mir
- pluripotent stem
- induced pluripotent
- cells
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 52
- 239000002679 microRNA Substances 0.000 title claims abstract description 31
- 210000004263 induced pluripotent stem cell Anatomy 0.000 title claims abstract description 30
- 108700011259 MicroRNAs Proteins 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 108091041877 miR-519d stem-loop Proteins 0.000 claims abstract description 14
- 108091086222 miR-520c stem-loop Proteins 0.000 claims abstract description 13
- 108091050113 miR-211 stem-loop Proteins 0.000 claims abstract description 12
- 108091023108 miR-30e stem-loop Proteins 0.000 claims abstract description 11
- 108091027549 miR-30e-1 stem-loop Proteins 0.000 claims abstract description 11
- 108091029213 miR-30e-2 stem-loop Proteins 0.000 claims abstract description 11
- 108091085488 miR-30e-3 stem-loop Proteins 0.000 claims abstract description 11
- 108091024082 miR-32 stem-loop Proteins 0.000 claims abstract description 10
- 108091062587 miR-32-1 stem-loop Proteins 0.000 claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims description 75
- 238000001890 transfection Methods 0.000 claims description 21
- 230000001464 adherent effect Effects 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 239000002502 liposome Substances 0.000 claims description 5
- 230000007910 cell fusion Effects 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- 210000001808 exosome Anatomy 0.000 claims description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 3
- 210000001728 clone cell Anatomy 0.000 claims description 2
- 230000006698 induction Effects 0.000 abstract description 29
- 238000005516 engineering process Methods 0.000 abstract description 17
- 108091070501 miRNA Proteins 0.000 abstract description 10
- 239000013612 plasmid Substances 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 12
- 230000008569 process Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 230000008672 reprogramming Effects 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 8
- 150000003384 small molecules Chemical class 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 7
- 238000012247 phenotypical assay Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 108091023040 Transcription factor Proteins 0.000 description 6
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 5
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 5
- 102000040945 Transcription factor Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 210000001082 somatic cell Anatomy 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108010082117 matrigel Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 241000711408 Murine respirovirus Species 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000010362 genome editing Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000001778 pluripotent stem cell Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091027977 Mir-200 Proteins 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108091031881 miR-290 stem-loop Proteins 0.000 description 1
- 108091072810 miR-294 stem-loop Proteins 0.000 description 1
- 108091076076 miR-295 stem-loop Proteins 0.000 description 1
- 108091030789 miR-302 stem-loop Proteins 0.000 description 1
- 108091074487 miR-34 stem-loop Proteins 0.000 description 1
- 108091092493 miR-34-1 stem-loop Proteins 0.000 description 1
- 108091059780 miR-34-2 stem-loop Proteins 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011206 morphological examination Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310265343.XA CN115975949B (zh) | 2023-03-20 | 2023-03-20 | 一种基于microRNA制备诱导性多能干细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310265343.XA CN115975949B (zh) | 2023-03-20 | 2023-03-20 | 一种基于microRNA制备诱导性多能干细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115975949A CN115975949A (zh) | 2023-04-18 |
CN115975949B true CN115975949B (zh) | 2023-09-01 |
Family
ID=85968557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310265343.XA Active CN115975949B (zh) | 2023-03-20 | 2023-03-20 | 一种基于microRNA制备诱导性多能干细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115975949B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011102444A1 (ja) * | 2010-02-18 | 2011-08-25 | 国立大学法人大阪大学 | 誘導多能性幹細胞の製造方法 |
CN108048484A (zh) * | 2017-11-14 | 2018-05-18 | 海南龄医疗产业发展有限公司 | 诱导性多能干细胞及其制备方法和应用 |
AU2019101052A4 (en) * | 2019-08-01 | 2019-10-17 | Zhejiang Huode Bioengineering Company Limited | Method for producing induced pluripotent stem cells by somatic cell reprogramming |
-
2023
- 2023-03-20 CN CN202310265343.XA patent/CN115975949B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011102444A1 (ja) * | 2010-02-18 | 2011-08-25 | 国立大学法人大阪大学 | 誘導多能性幹細胞の製造方法 |
CN108048484A (zh) * | 2017-11-14 | 2018-05-18 | 海南龄医疗产业发展有限公司 | 诱导性多能干细胞及其制备方法和应用 |
AU2019101052A4 (en) * | 2019-08-01 | 2019-10-17 | Zhejiang Huode Bioengineering Company Limited | Method for producing induced pluripotent stem cells by somatic cell reprogramming |
CN112301052A (zh) * | 2019-08-01 | 2021-02-02 | 浙江霍德生物工程有限公司 | 一种通过体细胞重编程制备诱导多功能干细胞的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115975949A (zh) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111454953B (zh) | 一种骨髓间充质干细胞成脂转化促进剂 | |
Tsulaia et al. | Glass needle-mediated microinjection of macromolecules and transgenes into primary human mesenchymal stem cells | |
CN116515740A (zh) | 一种低免疫原性iPSC细胞株 | |
JP7098187B2 (ja) | 多能性幹細胞及びその分化したt細胞と使用 | |
CN115975949B (zh) | 一种基于microRNA制备诱导性多能干细胞的方法 | |
JP2015534830A (ja) | マイクロrna及び細胞リプログラミング | |
CN111254110A (zh) | 一种将间充质干细胞转分化为精子的方法 | |
WO2012046065A2 (en) | Culture method | |
CN115807038A (zh) | 一种视网膜分化潜能细胞系CRX-Shen001及其构建方法 | |
CN113322234A (zh) | 永生化人cd34+cd38-造血干细胞系的制备方法及应用 | |
CN111808880A (zh) | 一种电转染缓冲液及其应用 | |
CN110904032A (zh) | 提高慢病毒转染人多能干细胞的方法 | |
CN116004548B (zh) | 一种基于外泌体递送microRNA制备诱导性多能干细胞的方法 | |
CN118165916A (zh) | 一种诱导性多能干细胞的制备方法 | |
CN111269940A (zh) | 一种使用转录因子foxo1直接转分化间充质干细胞为精子的方法 | |
CN116064660B (zh) | 绵羊诱导性多能干细胞及其制备方法 | |
CN111748514B (zh) | 一种提高膜片钳实验效率的方法 | |
CN114517210B (zh) | 一种t细胞向肿瘤迁移的负调控因子的体外筛选、鉴定方法 | |
CN114591915B (zh) | 一种大黄鱼体外诱导多能性干细胞的方法 | |
CN106190970B (zh) | 诱导脐带间充质干细胞直接转分化为红母细胞的方法 | |
CN113717935B (zh) | Nigroain-E1多肽在维持脂肪干细胞干性中的应用 | |
CN111793609B (zh) | 一种促进脂肪干细胞增殖和分化的方法 | |
Kumar et al. | Mapping regulators of cell fate determination: Approaches and challenges | |
EP4339272A1 (en) | Systems and methods for developing and optimizing cell culture processes | |
CN109852637B (zh) | 一种提高腺相关病毒转染效率的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 300452 building 20, Green Valley Health Industrial Park, No. 59, Kangtai Avenue, Binhai Science Park, high tech Zone, Binhai New Area, Tianjin Patentee after: Jiutian Lanyue Biotechnology (Tianjin) Co.,Ltd. Country or region after: China Address before: 300452 building 20, Green Valley Health Industrial Park, No. 59, Kangtai Avenue, Binhai Science Park, Binhai high tech Zone, Binhai New Area, Tianjin Patentee before: Tianjiu regenerative medicine (Tianjin) Technology Co.,Ltd. Country or region before: China |